PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer

Immunotherapies that targeting programmed cell death 1 (PD-1) and programmed death-ligand 1 (PD-L1) have obtained prominent success in breast cancer (BC). However, not all the patients benefit from the antibod...

Source: Cancer Cell International - September 9, 2019 Category: Cancer & Oncology Authors: Cui Jiang, SunRun Cao, Na Li, Lei Jiang and Tao Sun Tags: Primary research Source Type: research